Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC)-Reference-Cited by-同舟云学术

Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC)

Published:2014-09-18 Issue:10 Volume:27 Page:1687-1695
ISSN:0893-228X
Container-title:Chemical Research in Toxicology
language:en
Short-container-title:Chem. Res. Toxicol.

Author:

Ott Gudrun¹,Plitzko Birte¹,Krischkowski Carmen¹,Reichmann Debora²,Bittner Florian²,Mendel Ralf R.²,Kunze Thomas¹,Clement Bernd¹,Havemeyer Antje¹

Affiliation:

1. Department of Pharmaceutical and Medicinal Chemistry, Pharmaceutical Institute, Christian-Albrechts-University of Kiel, Gutenbergstrasse 76, D-24118 Kiel, Germany

2. Department of Plant Biology, Braunschweig University of Technology, Humboldtstrasse 1, D-38106 Braunschweig, Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

American Chemical Society (ACS)

Subject

Toxicology,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/tx500174u

Reference48 articles.

1. The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b5 in N-Reductive Metabolism in Human Cells

2. The fourth mammalian molybdenum enzyme mARC: current state of research

3. The Mitochondrial Amidoxime Reducing Component (mARC): Involvement in Metabolic Reduction ofN-Oxides, Oximes andN-Hydroxyamidinohydrazones

4. The Fourth Molybdenum Containing Enzyme mARC: Cloning and Involvement in the Activation of N-Hydroxylated Prodrugs

5. Reduction ofN-Hydroxy-sulfonamides, IncludingN-Hydroxy-valdecoxib, by the Molybdenum-Containing Enzyme mARC

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical and functional characterization of the p.A165T missense variant of mitochondrial amidoxime-reducing component 1;Journal of Biological Chemistry;2024-06

2. Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse;PLOS Genetics;2024-03-04

3. Mitochondrial amidoxime‐reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome;Liver International;2024-02-20

4. A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics;American Journal of Health-System Pharmacy;2024-02-13

5. The mitochondrial amidoxime reducing component—from prodrug-activation mechanism to drug-metabolizing enzyme and onward to drug target;Journal of Biological Chemistry;2023-11